Skip to content

Evaluating the effect of trans cranial direct current stimulation on myasthenia gravis

Evaluating the effect of transcranial current direct stimulation (TDCS) on improving muscle strength and easy fatigability in patients with myasthenia gravis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181109041598N1
Enrollment
15
Registered
2019-06-22
Start date
2018-09-12
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia gravis. Myasthenia gravis

Interventions

Intervention 1: "Intervention group: Real tDCS" In this group, participants receive one session electrical stimulation in the cerebral motor cortex. The duration of the stimulation is 20 minutes, the

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: patients who were diagnosed through medical criteria and laboratory tests were referred by a neurologist patients who were under MG treatment for at least 3 months prior to the study. under the medication with or without thymectomy The average age is 18 to 40 years old

Exclusion criteria

Exclusion criteria: Being pregnant psychological or neurological disorders MG crisis for at least 3 month prior to the study Having unsightly sleep on the night before the test and having a high fatigue on the day of the test Any history of consuming nicotine and substance abuse using caffeine in less than 5 hours

Design outcomes

Primary

MeasureTime frame
Muscular function of myasthenia gravis. Timepoint: In two rounds of the first and second sessions. Method of measurement: Quantitative Myasthenia Gravis (QMG)for Quantitative Measurement of Disease Symptoms, mannual mucle testing (MMT) for measuring muscle strength and MG-QOL15 (myasthenia gravis quality of life) for assessing the quality of life of a person with MG.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Nami

Shiraz University of Medical Sciences

torabinami@sums.ac.ir+98 71 3230 5471

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026